These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 19274670

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Malignant pleural mesothelioma: surgical management in 285 patients.
    Schipper PH, Nichols FC, Thomse KM, Deschamps C, Cassivi SD, Allen MS, Pairolero PC.
    Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
    [Abstract] [Full Text] [Related]

  • 4. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ, Wolf AS, Chirieac LR, Godleski JJ, Tilleman TR, Jaklitsch MT, Bueno R, Richards WG.
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [Abstract] [Full Text] [Related]

  • 5. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Aigner C, Hoda MA, Lang G, Taghavi S, Marta G, Klepetko W.
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
    [Abstract] [Full Text] [Related]

  • 6. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD, Boyer M, Tin MM, Wong D, Kennedy C, McLean J, Bannon PG, McCaughan BC.
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [Abstract] [Full Text] [Related]

  • 7. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
    Rusch VW, Piantadosi S, Holmes EC.
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):1-9. PubMed ID: 2072706
    [Abstract] [Full Text] [Related]

  • 8. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, Bains MS, Rusch VW.
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Extrapleural pneumonectomy of malignant pleural mesothelioma].
    Yoon HE, Nonaka K, Fukuhara K, Ueshima H, Sugiura T, Kaneda H, Shimamoto S, Imakita M, Iwase K.
    Kyobu Geka; 2004 Oct; 57(11):1011-5. PubMed ID: 15510813
    [Abstract] [Full Text] [Related]

  • 12. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
    Martin-Ucar AE, Nakas A, Edwards JG, Waller DA.
    Eur J Cardiothorac Surg; 2007 May; 31(5):765-70; discussion 770-1. PubMed ID: 17337201
    [Abstract] [Full Text] [Related]

  • 13. Mesothelioma at era of helical tomotherapy: results of two institutions in combining chemotherapy, surgery and radiotherapy.
    Sylvestre A, Mahé MA, Lisbona A, Zefkili S, Savignoni A, Bonnette P, Barthes Fle P, Paris E, Perigaud C, Yassa M, Giraud P.
    Lung Cancer; 2011 Dec; 74(3):486-91. PubMed ID: 21663996
    [Abstract] [Full Text] [Related]

  • 14. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P, Berruti A, Billé A, Lausi P, Levra MG, Giardino R, Ardissone F.
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M, McRae K, Anraku M, Karkouti K, Waddell TK, Pierre AF, Darling G, Keshavjee S, Johnston MR.
    Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
    [Abstract] [Full Text] [Related]

  • 16. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
    Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J, Yeap BY, Mujoomdar AA, Ducko CT, Bueno R, Sugarbaker DJ.
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
    [Abstract] [Full Text] [Related]

  • 17. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
    Sienel W, Kirschbaum A, Passlick B.
    Zentralbl Chir; 2008 Jun; 133(3):231-7. PubMed ID: 18563687
    [Abstract] [Full Text] [Related]

  • 18. [Recent progress in treatment of malignant pleural mesothelioma].
    Mahé MA, Cellerin L, Michaud JL, Sagan C, Supiot S, Le Péchoux C.
    Cancer Radiother; 2005 Nov; 9(6-7):362-5. PubMed ID: 16219479
    [Abstract] [Full Text] [Related]

  • 19. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
    Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):350-7. PubMed ID: 17467922
    [Abstract] [Full Text] [Related]

  • 20. [Malignant pleural mesothelioma].
    Kawamata O, Kondu Y, Murata T, Uetsuka H, Uda M, Nakai H, Ohta T.
    Kyobu Geka; 2007 Jan 01; 60(1):31-4. PubMed ID: 17249535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.